ENVB Enveric Biosciences
- 0.9800
- +0.0545+5.89%
- 0.9600
- -0.0200-2.04%
Enveric Biosciences News
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock
FibroGen, Acorda Therapeutics, Enveric Biosciences Among Healthcare Movers
SOL, MESO and ACOR Among Pre-market Losers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersARCA biopharma (NASDAQ:ABIO) stock moved upwards by 124.6% to $3.84 during Wednesday's pre-market session. The market value of their outstanding shares is at $55.6 million. Kintara Therapeutics
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionPartners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a P
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Nasdaq-listed psychedelics biotech Enveric Biosciences (NASDAQ:ENVB) shared its financial results for the fourth quarter of 2023 and the fiscal year ended December 31, 2023, results showing:Cash in ha
Enveric Biosciences Reports Q4 Results
Enveric Biosciences 4Q Loss/Shr $1.46 >ENVB
Enveric Biosciences 4Q Loss/Shr $1.46 >ENVB
BILI, EXAI and ENVB Among Pre-market Losers
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementClinical-stage psychedelics biopharma c
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersEtao International Co (NASDAQ:ETAO) stock rose 249.4% to $0.5 during Tuesday's after-market session. The company's market cap stands at $51.1 million. Taysha Gene Therapies (NASDAQ:TSHA) shares
Sector Update: Health Care Stocks Rise Late Afternoon
Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) increasing 0.4%. The iShares Biotechnology ETF (IBB) rose
Enveric Biosciences Canada Granted U.S. Patent #11931338: Nitrilated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Granted U.S. Patent #11931338: Nitrilated Psilocybin Derivatives and Methods of Using
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
Health care stocks rose Tuesday afternoon with the NYSE Health Care Index gaining 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%. The iShares Biotechnology ETF (IBB) advanced 0.6%. In
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise
Enveric Biosciences (ENVB) said Tuesday it signed two non-binding term sheets to out-license cannabinoid-COX-2 conjugate compounds for the treatment of joint diseases to an undisclosed biotechnology c
Enveric Biosciences Shares Pop 20% After Out-Licensing Deals Valued Up to $82M
By Denny Jacob Enveric Biosciences shares popped 20% to $1.32 after news of out-licensing cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for treatment of
Graphite Bio, SCWorx, Acurx Pharmaceuticals Among Healthcare Movers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersOntrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. The company's market cap stands at $14.3 million. Fusion Pharmaceuticals (NASDAQ:FUSN) shares rose 97.46% t
Enveric Gains on Out-licensing Deal of New Chemical Entities for Joint Disease Treatments
Analysis
Price Target
No Data
